$137 Million is the total value of HighVista Strategies LLC's 113 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 69.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BABA | Sell | ALIBABA GROUP HLDG LTDsponsored ads | $10,525,000 | +35.5% | 35,800 | -0.6% | 7.67% | +19.3% |
| INDA | Sell | ISHARES TRmsci india etf | $1,585,000 | +6.9% | 46,800 | -8.4% | 1.16% | -5.9% |
| SMIN | Sell | ISHARES TRmsci india sm cp | $1,358,000 | +18.9% | 37,900 | -3.1% | 0.99% | +4.7% |
| KURA | Sell | KURA ONCOLOGY INC | $761,000 | +56.9% | 24,833 | -16.5% | 0.56% | +38.1% |
| Sell | TRILLIUM THERAPEUTICS INC | $744,000 | +65.7% | 52,341 | -5.8% | 0.54% | +45.7% | |
| TGTX | Sell | TG THERAPEUTICS INC | $576,000 | +12.5% | 21,538 | -18.0% | 0.42% | -0.9% |
| STOK | Sell | STOKE THERAPEUTICS INC | $572,000 | +35.2% | 17,082 | -3.7% | 0.42% | +19.1% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $565,000 | +38.5% | 3,400 | -4.9% | 0.41% | +21.9% |
| CCXI | Sell | CHEMOCENTRYX INC | $515,000 | -8.4% | 9,395 | -3.8% | 0.38% | -19.4% |
| NVO | Sell | NOVO-NORDISK A Sadr | $493,000 | +1.6% | 7,100 | -4.1% | 0.36% | -10.7% |
| AXSM | Sell | AXSOME THERAPEUTICS INC | $428,000 | -25.0% | 6,012 | -13.4% | 0.31% | -34.0% |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $396,000 | -24.4% | 17,342 | -30.7% | 0.29% | -33.4% |
| CHKP | Sell | CHECK POINT SOFTWARE TECH LTord | $241,000 | -19.9% | 2,000 | -28.6% | 0.18% | -29.3% |
| KDMN | Sell | KADMON HLDGS INC | $93,000 | -78.5% | 23,700 | -72.0% | 0.07% | -81.1% |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $76,000 | +2.7% | 31,800 | -20.9% | 0.06% | -9.8% |
| PDLI | Exit | PDL BIOPHARMA INC | $0 | – | -12,700 | -100.0% | -0.03% | – |
| SACH | Exit | SACHEM CAP CORP | $0 | – | -12,500 | -100.0% | -0.03% | – |
| ATHX | Exit | ATHERSYS INC NEW | $0 | – | -18,800 | -100.0% | -0.04% | – |
| MNOV | Exit | MEDICINOVA INC | $0 | – | -11,700 | -100.0% | -0.05% | – |
| CPRX | Exit | CATALYST PHARMACEUTICALS INC | $0 | – | -15,800 | -100.0% | -0.06% | – |
| OSMT | Exit | OSMOTICA PHARMACEUTICALS PLC | $0 | – | -11,800 | -100.0% | -0.06% | – |
| PIRS | Exit | PIERIS PHARMACEUTICALS INC | $0 | – | -26,800 | -100.0% | -0.07% | – |
| MNKD | Exit | MANNKIND CORP | $0 | – | -48,600 | -100.0% | -0.07% | – |
| JNCE | Exit | JOUNCE THERAPEUTICS INC | $0 | – | -15,000 | -100.0% | -0.09% | – |
| TSU | Exit | TIM PARTICIPACOES S Asponsored adr | $0 | – | -11,300 | -100.0% | -0.12% | – |
| AKBA | Exit | AKEBIA THERAPEUTICS INC | $0 | – | -11,800 | -100.0% | -0.13% | – |
| SI | Exit | SILVERGATE CAP CORPcl a | $0 | – | -13,579 | -100.0% | -0.16% | – |
| SCCO | Exit | SOUTHERN COPPER CORP | $0 | – | -6,600 | -100.0% | -0.22% | – |
| BCEL | Exit | ATRECA INC | $0 | – | -15,330 | -100.0% | -0.27% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -11,266 | -100.0% | -0.31% | – |
| ALLK | Exit | ALLAKOS INC | $0 | – | -5,635 | -100.0% | -0.34% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -2,570 | -100.0% | -0.34% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -2,805 | -100.0% | -0.34% | – |
| RYTM | Exit | RHYTHM PHARMACEUTICALS INC | $0 | – | -18,609 | -100.0% | -0.34% | – |
| PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -8,198 | -100.0% | -0.34% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -3,384 | -100.0% | -0.34% | – |
| KALA | Exit | KALA PHARMACEUTICALS INC | $0 | – | -39,943 | -100.0% | -0.35% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -5,396 | -100.0% | -0.35% | – |
| ALEC | Exit | ALECTOR INC | $0 | – | -17,352 | -100.0% | -0.35% | – |
| VSTM | Exit | VERASTEM INC | $0 | – | -247,059 | -100.0% | -0.35% | – |
| CDXS | Exit | CODEXIS INC | $0 | – | -38,009 | -100.0% | -0.36% | – |
| SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -2,549 | -100.0% | -0.36% | – |
| TCDA | Exit | TRICIDA INC | $0 | – | -16,235 | -100.0% | -0.37% | – |
| ARVN | Exit | ARVINAS INC | $0 | – | -14,467 | -100.0% | -0.40% | – |
| EIDX | Exit | EIDOS THERAPEUTICS INC | $0 | – | -10,596 | -100.0% | -0.42% | – |
| PRNB | Exit | PRINCIPIA BIOPHARMA INC | $0 | – | -9,165 | -100.0% | -0.45% | – |
| LOGM | Exit | LOGMEIN INC | $0 | – | -34,109 | -100.0% | -2.39% | – |
| CZR | Exit | CAESARS ENTMT CORP | $0 | – | -342,418 | -100.0% | -3.44% | – |
| TECD | Exit | TECH DATA CORP | $0 | – | -54,600 | -100.0% | -6.55% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TRANSDIGM GROUP INC | 29 | Q2 2023 | 2.9% |
| VANGUARD INDEX FDS | 24 | Q4 2019 | 26.4% |
| APPLE INC | 24 | Q4 2019 | 2.0% |
| ISHARES TR | 22 | Q3 2018 | 7.9% |
| MICROSOFT CORP | 21 | Q3 2023 | 2.0% |
| VISA INC | 20 | Q3 2023 | 5.8% |
| INVESCO DB COMMDY INDX TRCK | 20 | Q3 2023 | 16.6% |
| VERIZON COMMUNICATIONS INC | 20 | Q4 2019 | 0.4% |
| ALIBABA GROUP HLDG LTD | 19 | Q3 2023 | 7.7% |
| AMAZON COM INC | 19 | Q3 2023 | 2.9% |
View HighVista Strategies LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| STG Group, Inc.Sold out | February 16, 2016 | 0 | 0.0% |
| SAExploration Holdings, Inc. | February 12, 2014 | 25,000 | 0.2% |
| Trio Merger Corp. | February 14, 2013 | 690,000 | 8.8% |
View HighVista Strategies LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View HighVista Strategies LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.